ArticleNeurology(R) neuroimmunology & neuroinflammation2022

Transitioning From S1P Receptor Modulators to B Cell-Depleting Therapies in Multiple Sclerosis: Clinical, Radiographic, and Laboratory Data.

William M Rowles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.